Market Overview

UPDATE: Benchmark Raises PT on Cardiovascular Systems on Fiscal 2014 Estimates

Related CSII
28 Stocks Moving In Monday's Pre-Market Session
Cardiovascular Systems (CSII) Hits 52-Week High on Solid Q3
9 Stocks Steven Cohen Keeps Buying (GuruFocus)

In a report published Friday, Benchmark Company analyst James Terwilliger reiterated his Speculative Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised his price target from $18.00 to $24.00.

In the report, Terwilliger noted, “We are publishing our fiscal 2014 revenue and EPS estimates of $125 million and ($0.78). This represents 25% revenue growth compared to our fiscal 2013 revenue estimate of $100 million. Our fiscal 2014 EPS estimate of ($0.78) compares favorably to our fiscal 2013 EPS estimate of ($1.09). The main driver of the improvement in our bottom line results is our assumption that CSII receives regulatory approval for their cardiology application with a subsequent launch in Q1:14 of calendar 2014.”

Cardiovascular Systems closed on Thursday at $20.30.

Latest Ratings for CSII

Sep 2017Raymond JamesInitiates Coverage OnMarket Perform
Jun 2017Bank of AmericaDowngradesNeutralUnderperform
Aug 2016Leerink SwannUpgradesMarket PerformOutperform

View More Analyst Ratings for CSII
View the Latest Analyst Ratings

Posted-In: Benchmark CompanyAnalyst Color Price Target Analyst Ratings


Related Articles (CSII)

View Comments and Join the Discussion!

Partner Center